Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8780892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterisation of a human glioblastoma cell line (LI) expressing hypothalamic and pituitary hormones

  2004cited by this paper
• Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor

  1995cited by this paper
• Polarity-specific activities of retinoic acid receptors determined by a co-repressor

  1995cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.

  1995cited by this paper
• Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.

  1995cited by this paper
• A transcriptional co-repressor that interacts with nuclear hormone receptors

  1995cited by this paper
• Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin.

  1995cited by this paper
• Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.

  1995cited by this paper
• The insulin-like growth factor I receptor: a key to tumor growth?

  1995cited by this paper
• Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.

  1995cited by this paper
• Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

  1995cited by this paper
• Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid.

  1995cited by this paper
• Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques.

  1995cited by this paper
• Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.

  1995cited by this paper
• Expression and Down‐Regulation by Retinoic Acid of IGF Binding Protein‐2 and ‐4 in Medium from Human Neuroblastoma Cells

  1994cited by this paper
• Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line.

  1994cited by this paper
• Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR beta 4‐like transgene.

  1994cited by this paper
• c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.

  1994cited by this paper
• Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I.

  1994cited by this paper
• Differential polysomal localization of human insulin-like-growth-factor-2 mRNAs in cell lines and foetal liver.

  1994cited by this paper
• Signals transduced via insulin-like growth factor I receptor (IGF(R)) mediate resistance to retinoic acid-induced cell growth arrest in a human neuroblastoma cell line.

  1994cited by this paper
• Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.

  1994cited by this paper
• Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells

  1994cited by this paper
• Expression of retinoic acid receptors alpha, beta, and gamma in human neuroblastoma cell lines.

  1994cited by this paper
• Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors.

  1994cited by this paper
• Characterization of the thermolysin-like cleavage of biologically active peptides by Xenopus laevis peptide hormone inactivating enzyme.

  1993cited by this paper
• Modulation of a novel thermolysin-like metallo-endopeptidase activity during retinoic acid-induced differentiation of human neuroectodermal tumor cell lines.

  1993cited by this paper
• Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-2.

  1993cited by this paper
• A new metallo- endopeptidase from human neuroblastoma NB-OK-1 cells which inactivates atrial natriuretic peptide by selective cleavage at the Ser123-Phe124 bond.

  1992cited by this paper
• Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action.

  1992cited by this paper
• Phenotype‐specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis

  1992cited by this paper
• A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion.

  1992cited by this paper
• Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line.

  1992cited by this paper
• Retinoic acid regulates gene expression of retinoic acid receptors alpha, beta and gamma in F9 mouse teratocarcinoma cells.

  1992cited by this paper
• Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6).

  1991cited by this paper
• Insulin-like growth factor II-mediated proliferation of human neuroblastoma.

  1991cited by this paper
• Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.

  1990cited by this paper
• Insulin-like growth factors I and II.

  1990cited by this paper
• Temporal changes in the expression of the insulin-like growth factor II gene associated with tissue maturation in the human fetus.

  1989cited by this paper
• Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

  1989cited by this paper
• Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.

  1989cited by this paper
• A single receptor binds both insulin-like growth factor II and mannose-6-phosphate.

  1988cited by this paper
• The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.

  1988cited by this paper
• Insulin degradation: mechanisms, products, and significance.

  1988cited by this paper
• The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.

  1988cited by this paper
• Expression and characterization of a functional human insulin-like growth factor I receptor.

  1988cited by this paper
• Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues.

  1987cited by this paper
• Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus.

  1987cited by this paper
• Tissue-Specific and Developmentally Regulated Transcription of the Insulin-Like Growth Factor 2 Gene

  1987cited by this paper
• The human insulin‐like growth factor II gene contains two development‐specific promoters

  1987cited by this paper
• Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.

  1984cited by this paper
• Insulin metabolism and degradation.

  1981cited by this paper
• Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.

  1980cited by this paper
• Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450ssc, in human steroidogenic tissues

  year unknowncited by this paper

• An in vitro model for vitamin A transport across the human blood–brain barrier

  2023cites this paper
• An in vitro model for vitamin A transport across the human blood-brain barrier

  2023cites this paper
• Therapeutic insights elaborating the potential of retinoids in Alzheimer’s disease

  2022cites this paper
• Association of Circulating Retinol and Α-TOH Levels with Cognitive Function in Aging Subject with Type 2 Diabetes Mellitus

  2020cites this paper
• A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

  2020cites this paper
• Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer’s Disease: a Review of Current Evidence

  2017cites this paper
• Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Aβ1-42 Injection in Rats

  2017cites this paper
• Rescue of Hypovitaminosis A Induces Non-Amyloidogenic Amyloid Precursor Protein (APP) Processing.

  2016cites this paper
• Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease

  2015cites this paper
• Cooperative Therapeutic Action of Retinoic Acid Receptor and Retinoid X Receptor Agonists in a Mouse Model of Alzheimer's Disease

  2014cites this paper
• Retinoids as potential targets for Alzheimer's disease.

  2014cites this paper
• Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease

  2014cites this paper
• The emerging roles of GPRC5A in diseases

  2014cites this paper
• Chapter 401 – Dactylysin

  2013cites this paper
• Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor protein.

  2013cites this paper
• Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease

  2013cites this paper
• TRAFFICKING OF ALPHA SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION

  2012cites this paper
• Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease

  2012cites this paper
• Drug repositioning for Alzheimer's disease

  2012cites this paper
• Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models.

  2011cites this paper
• TRAFFICKING OF α-SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION

  2011cites this paper
• Structure, function, and regulation of insulin-degrading enzyme.

  2009cites this paper
• All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease

  2009cites this paper
• Up‐regulation of the α‐secretase ADAM10 by retinoic acid receptors and acitretin

  2009cites this paper
• Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines

  2008cites this paper
• RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases.

  2008cites this paper
• Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease

  2006cites this paper
• The cornified envelope: a model of cell death in the skin

  2005cites this paper
• Expression and retinoid modulation of N-arginine dibasic convertase and an aminopeptidase-B in human neuroblastoma cell lines

  2004cites this paper
• Evidence for defective retinoid transport and function in late onset Alzheimer's disease

  2003cites this paper
• The Degradation of Amyloid β as a Therapeutic Strategy in Alzheimer's Disease and Cerebrovascular Amyloidoses

  2002cites this paper
• Synthesis and HPLC analysis of enzymatically cleavable linker consisting of poly(ethylene glycol) and dipeptide for the development of immunoconjugate.

  2000cites this paper
• Synthesis of a novel duocarmycin derivative DU-257 and its application to immunoconjugate using poly(ethylene glycol)-dipeptidyl linker capable of tumor specific activation.

  2000cites this paper
• Synergistic approach to cancer therapy: exploiting interactions between anti-estrogens, retinoids, monoterpenes and tyrosine kinase inhibitors.

  2000cites this paper
• Modulation of glutathione transferase P1–1 activity by retinoic acid in neuroblastoma cells

  1999cites this paper
• The cornified envelope: a model of cell death in the skin.

  1998cites this paper
• Expression of co-factors (SMRT and Trip-1) for retinoic acid receptors in human neuroectodermal cell lines.

  1997cites this paper
• Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.

  1997cites this paper
• Retinoic acid receptors beta and gamma distinguish retinoid signals for growth inhibition and neuritogenesis in human neuroblastoma cells.

  1996cites this paper
• International Journal of Molecular Sciences the Impact of Vitamin E and Other Fat-soluble Vitamins on Alzheimer´s Disease

  year unknowncites this paper